AI assistant
MYECO GROUP LTD — Capital/Financing Update 2013
May 20, 2013
65304_rns_2013-05-20_48a9b1fb-f29c-4cd0-ba66-8943cff43502.pdf
Capital/Financing Update
Open in viewerOpens in your device viewer
==> picture [588 x 74] intentionally omitted <==
==> picture [588 x 75] intentionally omitted <==
TO: COMPANY ANNOUNCEMENTS OFFICE ASX LIMITED
DATE: 21 May 2013
SHARE PLACEMENT UNDER LISTING RULES 7.1 AND 7.1A
The Board of Cardia Bioplastics Limited (“Cardia”) is pleased to announce that it is in process of raising up to $500,000 via placement offer to professional and sophisticated investors on the following terms:
-
Issue of 200 Million fully paid ordinary shares at an issue price of $0.0025 per share with one free new option for every two new shares subscribed.
-
New Options will have an exercise price of $0.0035 and an expiry date of 12 months from the date of issue.
-
New Options, once issued will be unlisted securities.
Funds raised will be used for general working capital requirements of the Company.
200 Million fully paid ordinary shares will be issued pursuant to the Company’s placement capacity available under Listing Rules 7.1 and 7.1A
Issue of 100 Million free new options is subject to Shareholders’ approval at a general meeting of members to be held in due course.
Settlement of Placement Funds is expected to be completed by tomorrow.
In addition, the Company will also seek shareholders’ approval at a General Meeting of Members, to place up to 430 Million fully paid ordinary shares at $0.0025 per share which can raise up to $1.075 million.
The Notice of General Meeting and related documentation will be released in due course.
Pat Volpe
Chairman
==> picture [593 x 62] intentionally omitted <==